To investigate the effect of exercise and diet intervention on blood lipid level in patients with hyperlipidemia. Methods: 680 patients with hyperlipidemia were detected from 5200 physical examiners, 566 patients were screened and randomly divided into intervention group and control group, each of which was 283 cases. The intervention group received reasonable diet and exercise guidance and weekly follow-up supervision. The control group did not perform the above intervention and did not take lipid-lowering drugs. And 6 months after the start of the observation period to observe the expiration of the enzymatic determination were used respectively in the blood triglyceride (TG), total cholesterol (TC), low density lipoprotein (LDL -C), high density lipoprotein (HDL -C), total cholesterol and the ratio of high density lipoprotein cholesterol (HDL -C), low density lipoprotein and the ratio of HDL levels of change, and statistical analysis. Results: In the intervention group, TG decreased from (2.94±0.49) mmol/L to (2.16±0.83)mmol/L, TC decreased from (6.58±0.42)mmol/L to (5.21±0.39)mmol/L, and LDL-C decreased from (4.42±0.36) mmol/L to (3.38±0.31) mmol/L. Conclusion: Diet and exercise can effectively improve the level of blood lipid in patients and can be used as non-drug therapy for patients with hyperlipidemia.

Jing Li. Effects of Exercise and Diet Intervention on Serum Lipid Level in Patients with Hyperlipidemia. International Journal of Public Health and Preventive Medicine (2020), Vol. 1, Issue 2: 12-23.   https://doi.org/10.38007/IJPHPM.2020.010202.

[1] Hua Miao, Li Zhang, Dan-Qian Chen.(2017). “Urinary Biomarker and Treatment Mechanism of Rhizoma Alismatis on Hyperlipidemia”, Biomedical Chromatography, 31(4),pp.3829. https://doi.org/10.1002/bmc.3829

[2] Y. Zhang, D D Wei, R R Yuan.(2017). “Effects of ApoE gene Polymorphism on the Efficacy of Atorvastatin in the Treatment of Hyperlipidemia”, Zhonghua Yi Xue Za Zhi, 97(4),pp.291-294.

[3] Lee Y, Tien N I, Lin C.(2018). “Association of Antituberculosis Treatment and Lower Risk of Hyperlipidemia in Taiwanese Patients: A Population-Based Case–Control Study”, Vivo, 32(1),pp.47. https://doi.org/10.21873/invivo.11203

[4] C.N. Sarvesh, Jennifer Fernandes, Suresh Janadri.(2017). “Antihyperlipidemic Activity of Achyranthes Aspera Linn Leaves on Cholesterol Induced Hyperlipidemia in Rats”, Research Journal of Pharmacy & Technology, 10(1),pp.200.

[5] Mehanna ET, Barakat BM, ElSayed MH.(2018). “An Optimized Dose of Raspberry Ketones Controls Hyperlipidemia and Insulin Resistance in Male Obese Rats: Effect on Adipose Tissue Expression of Adipocytokines and Aquaporin 7”, European Journal of Pharmacology, 832(8),pp.81-89. https://doi.org/10.1016/j.ejphar.2018.05.028

[6] Rebekah M. Jackowski, Elizabeth K. Pogge, Nicole K. Early.(2017). “Provision of Lifestyle Counseling and the Prescribing of Pharmacotherapy for Hyperlipidemia Among US Ambulatory Patients: A National Assessment of Office-Based Physician Visits”, Am J Cardiovasc Drugs, 18(11),pp.1-7. https://doi.org/10.1007/s40256-017-0247-y

[7] Rangel-Castilla Leonardo, Siddiqui Adnan H.(2018). “Nuances of Endovascular Treatment of Transverse/Sigmoid Sinus Stenosis With Stenting Venoplasty in a Patient With Pseudotumor Cerebri: 2-Dimensional Operative Video”, Operative Neurosurgery, 16(3),pp.393-394. https://doi.org/10.1093/ons/opy174

[8] Ganjikunta Venkata Subbaiah, Korivi Mallikarjuna, Bhasha Shanmugam.(2017). “Ginger Treatment Ameliorates Alcohol-induced Myocardial Damage by Suppression of Hyperlipidemia and Cardiac Biomarkers in Rats”, Pharmacognosy Magazine, 13(1),pp.69-75. https://doi.org/10.4103/0973-1296.203891

[9] Zhong Xian, Yan Liu, Wenjuan Xu.(2017). “The Anti-hyperlipidemia Effects of Raw Polygonum Multiflorum Extract in Vivo”, Biological & Pharmaceutical Bulletin, 40(11),pp.1839-1845. https://doi.org/10.1248/bpb.b17-00218

[10] Pham H T T, Huang W, Han C.(2017). “Effects of Averrhoa Carambola L. (Oxalidaceae) Juice Mediated on Hyperglycemia, Hyperlipidemia, and its Influence on Regulatory Protein Expression in the Injured Kidneys of Streptozotocin-induced Diabetic Mice”, American Journal of Translational Research, 9(1),pp.36-49.

[11] N.K. Devaraj, M. Mohamed, N. Hussein.(2017). “Prevalence, Factors Influencing, and Knowledge About Adherence to Lipid-Lowering Therapy Among Hyperlipidemia Patients”, Medical Journal of Malaysia, 72(3),pp.157-164. https://doi.org/10.1016/j.ijcard.2017.09.047

[12] Sreya Bagchi, Ying He, Hong Zhang.(2017). “CD1b-autoreactive T Cells Contribute to Hyperlipidemia-induced Skin Inflammation in Mice”, Journal of Clinical Investigation, 127(6),pp.2339-2352. https://doi.org/10.1172/JCI92217